Jacqueline M Smith1, Joel Mader1, Andrew C H Szeto2, Amelia M Arria3, Ken C Winters4,5, T Chris R Wilkes6,7. 1. 1 Faculty of Nursing, University of Calgary, Calgary, Alberta. 2. 2 Department of Psychology and Office of the Provost, University of Calgary, Calgary, Alberta. 3. 3 Department of Behavioural and Community Health, Centre on Young Adult Health and Development, School of Public Health, University of Maryland, College Park, MD, USA. 4. 4 Oregon Research Institute, Eugene, OR, USA. 5. 5 Department of Psychology, University of Minnesota, Minneapolis, MN, USA. 6. 6 Alberta Health Services, Alberta. 7. 7 Cumming School of Medicine, University of Calgary, Calgary, Alberta.
Abstract
OBJECTIVE: The study sought to describe a Canadian sample of university students' medicinal use of cannabis, including prevalence of cannabis use disorder (CUD) and replacement of traditional treatments with cannabis. METHOD: A random sample of 4000 university students was asked to complete a cross-sectional web-based survey. The survey was completed by 2212 (average age 23.2 years, SD = 5.2 years), representing a 55.3% response rate. To be eligible, students had to be enrolled in a class on campus and were 18 years or older. RESULT: Half (52%) of respondents used cannabis at least once in their lifetime, with ∼11% reporting medicinal cannabis use. Recreational motives to use cannabis were common among medicinal users (85%), several (38%) replaced traditional medication with cannabis, and more than a third received authorization by a health care provider. Of the medicinal users, 13.6% met the criteria for CUD. Common ailments for medicinal cannabis use were anxiety, sleep problems, depression, and pain. When mental health-related categories are combined, 78.2% of medicinal users used for at least 1 mental health condition. CONCLUSIONS: Medicinal cannabis use occurs among university students. None of the ailments listed by medicinal users meet the Canadian Family Physicians prescribing guidelines, and most are not among those viewed by the National Academies of Science, Engineering, and Medicine as having strong evidence for therapeutic value. The results raise concerns for health care providers who are authorizing or counselling patients' considering medicinal cannabis.
OBJECTIVE: The study sought to describe a Canadian sample of university students' medicinal use of cannabis, including prevalence of cannabis use disorder (CUD) and replacement of traditional treatments with cannabis. METHOD: A random sample of 4000 university students was asked to complete a cross-sectional web-based survey. The survey was completed by 2212 (average age 23.2 years, SD = 5.2 years), representing a 55.3% response rate. To be eligible, students had to be enrolled in a class on campus and were 18 years or older. RESULT: Half (52%) of respondents used cannabis at least once in their lifetime, with ∼11% reporting medicinal cannabis use. Recreational motives to use cannabis were common among medicinal users (85%), several (38%) replaced traditional medication with cannabis, and more than a third received authorization by a health care provider. Of the medicinal users, 13.6% met the criteria for CUD. Common ailments for medicinal cannabis use were anxiety, sleep problems, depression, and pain. When mental health-related categories are combined, 78.2% of medicinal users used for at least 1 mental health condition. CONCLUSIONS: Medicinal cannabis use occurs among university students. None of the ailments listed by medicinal users meet the Canadian Family Physicians prescribing guidelines, and most are not among those viewed by the National Academies of Science, Engineering, and Medicine as having strong evidence for therapeutic value. The results raise concerns for health care providers who are authorizing or counselling patients' considering medicinal cannabis.
Authors: Simon J Adamson; Frances J Kay-Lambkin; Amanda L Baker; Terry J Lewin; Louise Thornton; Brian J Kelly; J Douglas Sellman Journal: Drug Alcohol Depend Date: 2010-03-26 Impact factor: 4.492
Authors: G Michael Allan; Jamil Ramji; Danielle Perry; Joey Ton; Nathan P Beahm; Nicole Crisp; Beverly Dockrill; Ruth E Dubin; Ted Findlay; Jessica Kirkwood; Michael Fleming; Ken Makus; Xiaofu Zhu; Christina Korownyk; Michael R Kolber; James McCormack; Sharon Nickel; Guillermina Noël; Adrienne J Lindblad Journal: Can Fam Physician Date: 2018-02 Impact factor: 3.275
Authors: Aaron L Sarvet; Melanie M Wall; Katherine M Keyes; Magdalena Cerdá; John E Schulenberg; Patrick M O'Malley; Lloyd D Johnston; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2018-03-01 Impact factor: 4.492
Authors: Daniel Ziemianski; Rielle Capler; Rory Tekanoff; Anaïs Lacasse; Francesca Luconi; Mark A Ware Journal: BMC Med Educ Date: 2015-03-19 Impact factor: 2.463
Authors: Jessica M Round; Cerina Lee; John G Hanlon; Elaine Hyshka; Jason R B Dyck; Dean T Eurich Journal: BMC Public Health Date: 2020-06-23 Impact factor: 3.295
Authors: Jacqueline Smith; Jennifer Smith; Joel Mader; Gabrielle Guestier; Lauren Conn; Joy Maddigan Journal: J Behav Health Serv Res Date: 2021-07-08 Impact factor: 1.475
Authors: Cerina Lee; Mu Lin; Karen J B Martins; Jason R B Dyck; Scott Klarenbach; Lawrence Richer; Ed Jess; John G Hanlon; Elaine Hyshka; Dean T Eurich Journal: BMC Public Health Date: 2021-05-01 Impact factor: 3.295